CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 186 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,632,425 | +21.6% | 3,143,051 | -0.7% | 0.01% | +25.0% |
| Q2 2023 | $70,450,042 | -1.2% | 3,166,294 | -3.8% | 0.00% | 0.0% |
| Q1 2023 | $71,281,002 | -45.1% | 3,290,905 | -48.6% | 0.00% | 0.0% |
| Q4 2022 | $129,930,950 | +46.3% | 6,397,388 | +84.7% | 0.00% | -33.3% |
| Q3 2022 | $88,807,000 | +6.7% | 3,463,598 | -1.0% | 0.01% | +20.0% |
| Q2 2022 | $83,217,000 | +8.4% | 3,499,446 | +2.6% | 0.01% | +25.0% |
| Q1 2022 | $76,783,000 | +17.2% | 3,409,558 | +3.1% | 0.00% | +33.3% |
| Q4 2021 | $65,508,000 | +1.7% | 3,308,480 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $64,408,000 | -10.8% | 3,272,743 | -0.3% | 0.00% | -25.0% |
| Q2 2021 | $72,201,000 | -5.8% | 3,281,872 | +1.8% | 0.00% | 0.0% |
| Q1 2021 | $76,674,000 | -9.3% | 3,222,957 | -0.2% | 0.00% | -20.0% |
| Q4 2020 | $84,508,000 | +53.3% | 3,230,432 | +2.0% | 0.01% | +25.0% |
| Q3 2020 | $55,141,000 | -0.3% | 3,168,091 | -3.7% | 0.00% | 0.0% |
| Q2 2020 | $55,324,000 | +46.6% | 3,289,193 | +3.6% | 0.00% | +33.3% |
| Q1 2020 | $37,746,000 | +3.0% | 3,174,603 | +4.9% | 0.00% | 0.0% |
| Q4 2019 | $36,633,000 | -11.1% | 3,027,521 | +3.8% | 0.00% | 0.0% |
| Q3 2019 | $41,211,000 | +23.1% | 2,915,521 | -2.9% | 0.00% | +50.0% |
| Q2 2019 | $33,474,000 | -9.2% | 3,002,187 | -4.4% | 0.00% | -33.3% |
| Q1 2019 | $36,860,000 | -6.2% | 3,139,718 | +6.7% | 0.00% | -25.0% |
| Q4 2018 | $39,310,000 | -13.1% | 2,942,351 | -8.8% | 0.00% | +33.3% |
| Q3 2018 | $45,242,000 | -1.0% | 3,226,986 | +10.9% | 0.00% | -25.0% |
| Q2 2018 | $45,720,000 | -11.4% | 2,908,557 | -7.3% | 0.00% | 0.0% |
| Q1 2018 | $51,596,000 | -0.6% | 3,136,704 | +9.2% | 0.00% | 0.0% |
| Q4 2017 | $51,889,000 | +38.3% | 2,872,993 | +47.8% | 0.00% | +33.3% |
| Q3 2017 | $37,507,000 | +56.7% | 1,943,304 | -4.2% | 0.00% | +50.0% |
| Q2 2017 | $23,931,000 | +35.8% | 2,028,013 | +26.1% | 0.00% | 0.0% |
| Q1 2017 | $17,623,000 | +92.7% | 1,607,874 | +27.6% | 0.00% | +100.0% |
| Q4 2016 | $9,147,000 | +16.8% | 1,260,066 | +4.6% | 0.00% | 0.0% |
| Q3 2016 | $7,829,000 | +23.3% | 1,204,533 | +3.6% | 0.00% | 0.0% |
| Q2 2016 | $6,350,000 | +50.4% | 1,162,939 | +28.9% | 0.00% | – |
| Q1 2016 | $4,222,000 | -2.3% | 902,240 | +3.9% | 0.00% | – |
| Q4 2015 | $4,322,000 | +35.1% | 868,791 | +2.0% | 0.00% | – |
| Q3 2015 | $3,200,000 | -36.5% | 851,519 | +1.5% | 0.00% | -100.0% |
| Q2 2015 | $5,043,000 | -8.9% | 838,897 | -15.2% | 0.00% | 0.0% |
| Q1 2015 | $5,538,000 | +91.7% | 988,996 | +2.8% | 0.00% | – |
| Q4 2014 | $2,889,000 | +12.7% | 962,289 | +0.5% | 0.00% | – |
| Q3 2014 | $2,563,000 | +0.7% | 957,422 | +5.4% | 0.00% | – |
| Q2 2014 | $2,544,000 | -26.8% | 908,433 | +14.0% | 0.00% | – |
| Q1 2014 | $3,477,000 | +4.2% | 797,148 | -44.4% | 0.00% | – |
| Q4 2013 | $3,336,000 | +202.7% | 1,434,367 | +106.2% | 0.00% | – |
| Q3 2013 | $1,102,000 | -8.2% | 695,620 | +0.3% | 0.00% | – |
| Q2 2013 | $1,200,000 | – | 693,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |